These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 24114037)

  • 1. The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study.
    Cleeland CS; Zhao F; Chang VT; Sloan JA; O'Mara AM; Gilman PB; Weiss M; Mendoza TR; Lee JW; Fisch MJ
    Cancer; 2013 Dec; 119(24):4333-40. PubMed ID: 24114037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The validity and utility of the M. D. Anderson Symptom Inventory in patients with breast cancer: evidence from the symptom outcomes and practice patterns data from the eastern cooperative oncology group.
    Mendoza TR; Zhao F; Cleeland CS; Wagner LI; Patrick-Miller LJ; Fisch MJ
    Clin Breast Cancer; 2013 Oct; 13(5):325-34. PubMed ID: 23816985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The symptom burden of primary brain tumors: evidence for a core set of tumor- and treatment-related symptoms.
    Armstrong TS; Vera-Bolanos E; Acquaye AA; Gilbert MR; Ladha H; Mendoza T
    Neuro Oncol; 2016 Feb; 18(2):252-60. PubMed ID: 26289592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the Amharic Version of the M. D. Anderson Symptom Inventory and Assessment of Symptoms in Ethiopian Cancer Patients.
    Anshabo AT; Migbaru S; Mulu A; Negusu D; Asfaw AA; Awoke D; Tigeneh W; Engidawork E
    J Pain Symptom Manage; 2016 May; 51(5):947-53. PubMed ID: 26988847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptom burden of cancer patients: validation of the German M. D. Anderson Symptom Inventory: a cross-sectional multicenter study.
    Schmidt H; Cleeland CS; Bauer A; Landenberger M; Jahn P
    J Pain Symptom Manage; 2015 Jan; 49(1):117-25. PubMed ID: 24858739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability and validity of the M. D. Anderson Symptom Inventory-Spine Tumor Module.
    Armstrong TS; Gning I; Mendoza TR; Vera-Bolanos E; Gilbert MR; Rhines LD; Weinberg JS; Sanchez-Williams G; Levin V; Burton AW; Cleeland C
    J Neurosurg Spine; 2010 Apr; 12(4):421-30. PubMed ID: 20367379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep quality and its association with fatigue, symptom burden, and mood in patients with advanced cancer in a clinic for early-phase oncology clinical trials.
    George GC; Iwuanyanwu EC; Anderson KO; Yusuf A; Zinner RG; Piha-Paul SA; Tsimberidou AM; Naing A; Fu S; Janku F; Subbiah V; Cleeland CS; Mendoza TR; Hong DS
    Cancer; 2016 Nov; 122(21):3401-3409. PubMed ID: 27412379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer-related symptom assessment in France: validation of the French M. D. Anderson Symptom Inventory.
    Guirimand F; Buyck JF; Lauwers-Allot E; Revnik J; Kerguen T; Aegerter P; Brasseur L; Cleeland CS
    J Pain Symptom Manage; 2010 Apr; 39(4):721-33. PubMed ID: 20413059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The validity and utility of the MD Anderson Symptom Inventory in patients with prostate cancer: evidence from the Symptom Outcomes and Practice Patterns (SOAPP) data from the Eastern Cooperative Oncology Group.
    Jones D; Zhao F; Fisch MJ; Wagner LI; Patrick-Miller LJ; Cleeland CS; Mendoza TR
    Clin Genitourin Cancer; 2014 Feb; 12(1):41-9. PubMed ID: 24126238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom Inventory.
    Mendoza TR; Wang XS; Lu C; Palos GR; Liao Z; Mobley GM; Kapoor S; Cleeland CS
    Oncologist; 2011; 16(2):217-27. PubMed ID: 21285393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptability of Routine Evaluations Using Patient-Reported Outcomes of Common Terminology Criteria for Adverse Events and Other Patient-Reported Symptom Outcome Tools in Cancer Outpatients: Princess Margaret Cancer Centre Experience.
    Albaba H; Barnes TA; Veitch Z; Brown MC; Shakik S; Su S; Naik H; Wang T; Liang M; Perez-Cosio A; Eng L; Mittmann N; Xu W; Howell D; Liu G
    Oncologist; 2019 Nov; 24(11):e1219-e1227. PubMed ID: 31409744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors.
    Wang XS; Zhao F; Fisch MJ; O'Mara AM; Cella D; Mendoza TR; Cleeland CS
    Cancer; 2014 Feb; 120(3):425-32. PubMed ID: 24436136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer.
    Sailors MH; Bodurka DC; Gning I; Ramondetta LM; Williams LA; Mendoza TR; Agarwal S; Sun CC; Cleeland CS
    Gynecol Oncol; 2013 Aug; 130(2):323-8. PubMed ID: 23685012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every 2 weeks.
    Gabrilove JL; Perez EA; Tomita DK; Rossi G; Cleeland CS
    Cancer; 2007 Oct; 110(7):1629-40. PubMed ID: 17694552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telephone interventions for symptom management in adults with cancer.
    Ream E; Hughes AE; Cox A; Skarparis K; Richardson A; Pedersen VH; Wiseman T; Forbes A; Bryant A
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD007568. PubMed ID: 32483832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module.
    Rosenthal DI; Mendoza TR; Fuller CD; Hutcheson KA; Wang XS; Hanna EY; Lu C; Garden AS; Morrison WH; Cleeland CS; Gunn GB
    Cancer; 2014 Jul; 120(13):1975-84. PubMed ID: 24711162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of baseline symptom burden in treatment-naïve patients with lung cancer: an observational study.
    Mendoza TR; Kehl KL; Bamidele O; Williams LA; Shi Q; Cleeland CS; Simon G
    Support Care Cancer; 2019 Sep; 27(9):3439-3447. PubMed ID: 30661202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast Cancer.
    Nyrop KA; Deal AM; Shachar SS; Basch E; Reeve BB; Choi SK; Lee JT; Wood WA; Anders CK; Carey LA; Dees EC; Jolly TA; Reeder-Hayes KE; Kimmick GG; Karuturi MS; Reinbolt RE; Speca JC; Muss HB
    Oncologist; 2019 Jun; 24(6):762-771. PubMed ID: 30552158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chinese version of the M. D. Anderson Symptom Inventory: validation and application of symptom measurement in cancer patients.
    Wang XS; Wang Y; Guo H; Mendoza TR; Hao XS; Cleeland CS
    Cancer; 2004 Oct; 101(8):1890-901. PubMed ID: 15386315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in Symptom Burden Among Cancer Patients With Different Stages of Cachexia.
    Zhou T; Yang K; Thapa S; Liu H; Wang B; Yu S
    J Pain Symptom Manage; 2017 May; 53(5):919-926. PubMed ID: 28062340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.